SLLK, Control Peptide for TSP1 Inhibitor
SLLK, Control Peptide for TSP1 Inhibitor is a control peptide for LSKL (leucine-serine-lysine-leucine) .
Product Specifications
CAS Number
2918768-29-1
UNSPSC
12352209
Target
TGF-β Receptor
Type
Peptides
Related Pathways
TGF-beta/Smad
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/SLLK,_Control_Peptide_for_TSP1_Inhibitor.html
Solubility
H2O
Smiles
O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N)=O)=O)=O)[C@H](CO)N
Molecular Formula
C21H42N6O5
Molecular Weight
458.60
References & Citations
[1]Krishna SM, et al. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse. Arterioscler Thromb Vasc Biol. 2015 Feb;35 (2) :389-98.|[2]Lu A, et al. Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am J Pathol. 2011 Jun;178 (6) :2573-86.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB0901-500 1x 500 µL
Adenosine Monophosphate Deaminase 3 (AMPD3) (AMPD3/901), 0.2mg/mL
Sign In for Pricing
View Details ![FITC Anti-Human IFN-γ Antibody[B27]](https://cdn.genprice.uk/products/763/68dd14a1061270361e7d080e/imageurl/e-ab-f1196c.webp)
